Stotles logo
Stale pre-tender

RSV Immunisations 2024

Published

Description

The provision of immunisation products indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) lower respiratory tract disease Lot 1: A monoclonal antibody for infants The provision of a product indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) in infants from birth, including pre-term infants, weighing less than 5 kilograms by direct passive immunisation of the infant by means of a monoclonal antibody. The contracting authority estimates their requirement for deliveries between 1 July 2024 and 30 June 2026 ('Initial Term') of the contract to be up to 1.6 million doses, with the option to extend for up to an additional 24 months. Lot 4: A vaccine for older adults (annual cohort and a catch-up volume) The provision of a product indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) in a routine single annual cohort of older adults with a catch up for multiple cohorts in the first year. The contracting authority estimates their requirement for deliveries between 1 July 2024 and 30 June 2026 ('Initial Term') of the contract to be up to 4 million doses, with the option to extend for up to an additional 24 months. Lot 3: A vaccine for older adults (annual cohort) The provision of a product indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) in a routine single annual cohort of older adults. The contracting authority estimates their requirement for deliveries between 1 July 2024 and 30 June 2026 ('Initial Term') of the contract to be up to 1.45 million doses, with the option to extend for up to an additional 24 months. Lot 2: A vaccine which provides maternal protection The provision of a product indicated for the prevention or protection from RSV in infants by means of a vaccination given to pregnant women. The contracting authority estimates their requirement for deliveries between 1 July 2024 and 30 June 2026 ('Initial Term') of the contract to be up to 1.69 million doses, with the option to extend for up to an additional 24 months.

Timeline

Publish date

a year ago

Buyer information

UK Health Security Agency

Contact:
Chantal Jockel
Email:
chantal.jockel@ukhsa.gov.uk

Explore contracts and tenders relating to UK Health Security Agency

Go to buyer profile

Notice topic

To save this opportunity, sign up to Stotles for free.
Save in app
  • Looking glass on top of a file iconTender tracking

    Access a feed of government opportunities tailored to you, in one view. Receive email alerts and integrate with your CRM to stay up-to-date.

  • ID card iconProactive prospecting

    Get ahead of competitors by reaching out to key decision-makers within buying organisations directly.

  • Open folder icon360° account briefings

    Create in-depth briefings on buyer organisations based on their historical & upcoming procurement activity.

  • Teamwork iconCollaboration tools

    Streamline sales workflows with team collaboration and communication features, and integrate with your favourite sales tools.

Stop chasing tenders, start getting ahead.

Create your free feed

Explore similar tenders and contracts

Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.

Explore other contracts published by UK Health Security Agency

Explore more open tenders, recent contract awards and upcoming contract expiries published by UK Health Security Agency.

Explore more suppliers to UK Health Security Agency

Sign up